Williams Gregg bought 48,100 shares of Vivani Medical, Inc. at $0.99 for $47.8k on Nov 13, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Director
DIR
Filed Nov 16, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$47,763.30Shares × reported price
Shares traded
48,100Common Stock
Price per share
$0.99Reported price. Read footnotes for ranges.
% of reported position traded
0.13%This security and ownership context
Holdings after
36,960,836Indirect · See footnote
Trade date
Nov 13, 2026Buy
Filed
Nov 16, 2026, 8:00 AM ET3-day reporting delay
Accession
0001753926-26-002141Code P · Transaction 401674
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 36,912,736 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

VANI price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
VANI · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 23, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +15%1w ago +5.9%1d ago −3%
Returns since7d30d90d180d1y

Footnotes in full

F1: Individual purchased shares on the open market. F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.921 to $1.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: The reporting person owns 41,760,036 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 34,835,084 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.